The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Sandoz, a global leader in generic and biosimilar medicines, opens new production facility in Kundl, Austria Facility aims to provide affordable lifesaving drugs solely manufactured in Europe,
AbbVie commenced the construction of a new expansion at its Singapore manufacturing facility, emphasizing its commitment
AGC Biologics is planning to build a new manufacturing facility at AGC Incs Yokohama Technical Center in Japan This expansion is part of AGC Biologics strategic growth strategy to enhance pharmaceutical development
FUJIFILM Cellular Dynamics, specializing in human induced pluripotent stem cells and iPSCderived cells, and FUJIFILM Diosynth Biotechnologies in California, a prominent CDMO in biologics and advanced therapies,
Eli Lilly and Company plans to build a hightech manufacturing facility in Alzey, Rhineland Palatinate, Germany
Aragen, a leading CRDMO specializing in small molecules and biologics, is establishing a new biologics manufacturing facility in Bangalore, India
The facility aims to produce cell and gene therapies on a global scale, making them more accessible worldwide
Sandozs investment sets the stage for a significant transformation of the Ljubljana site into a central hub for advancing biosimilar products within the company
The Novo Nordisk Foundation is embarking on a groundbreaking journey, dedicating its resources to forge a stateoftheart facility that will serve as the ultimate crucible
McCord Development is strengthening its presence in the life sciences and biomanufacturing sector with the launch of BioHub Two
